- Home
- EDIT vs WMPN Comparison
EDIT vs WMPN Comparison
Compare EDIT & WMPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- WMPN
- Stock Information
- Founded
- EDIT 2013
- WMPN 1870
- Country
- EDIT United States
- WMPN United States
- Employees
- EDIT N/A
- WMPN N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- WMPN Savings Institutions
- Sector
- EDIT Health Care
- WMPN Finance
- Exchange
- EDIT Nasdaq
- WMPN Nasdaq
- Market Cap
- EDIT 99.9M
- WMPN 104.2M
- IPO Year
- EDIT 2016
- WMPN N/A
- Fundamental
- Price
- EDIT $1.21
- WMPN $12.55
- Analyst Decision
- EDIT Buy
- WMPN Buy
- Analyst Count
- EDIT 14
- WMPN 1
- Target Price
- EDIT $8.08
- WMPN $14.00
- AVG Volume (30 Days)
- EDIT 2.7M
- WMPN 14.4K
- Earning Date
- EDIT 02-26-2025
- WMPN 01-15-2025
- Dividend Yield
- EDIT N/A
- WMPN 0.99%
- EPS Growth
- EDIT N/A
- WMPN N/A
- EPS
- EDIT N/A
- WMPN N/A
- Revenue
- EDIT $61,759,000.00
- WMPN $20,363,000.00
- Revenue This Year
- EDIT N/A
- WMPN N/A
- Revenue Next Year
- EDIT N/A
- WMPN N/A
- P/E Ratio
- EDIT N/A
- WMPN N/A
- Revenue Growth
- EDIT 150.95
- WMPN N/A
- 52 Week Low
- EDIT $1.12
- WMPN $10.80
- 52 Week High
- EDIT $11.58
- WMPN $13.87
- Technical
- Relative Strength Index (RSI)
- EDIT 34.86
- WMPN 59.49
- Support Level
- EDIT $1.15
- WMPN $11.18
- Resistance Level
- EDIT $1.27
- WMPN $13.08
- Average True Range (ATR)
- EDIT 0.10
- WMPN 0.32
- MACD
- EDIT 0.04
- WMPN 0.12
- Stochastic Oscillator
- EDIT 21.11
- WMPN 72.11
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About WMPN William Penn Bancorporation
William Penn Bancorporation operates as an independent community financial services provider. The bank offers traditional banking and related financial services to individual, business, and government customers. Through its branch and automated teller machine network, the bank offers a full array of commercial and retail financial services, including; the taking of time, savings, and demand deposits; the making of commercial, consumer, and mortgage loans; and the providing of other financial services.